Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
45.81
-0.37 (-0.80%)
At close: Jun 5, 2026, 4:00 PM EDT
46.72
+0.91 (1.99%)
After-hours: Jun 5, 2026, 7:53 PM EDT
Travere Therapeutics Employees
Travere Therapeutics had 497 employees as of December 31, 2025. The number of employees increased by 112 or 29.09% compared to the previous year.
Employees
497
Change (1Y)
112
Growth (1Y)
29.09%
Revenue / Employee
$1,078,863
Profits / Employee
-$43,103
Market Cap
4.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 497 | 112 | 29.09% |
| Dec 31, 2024 | 385 | 5 | 1.32% |
| Dec 31, 2023 | 380 | -82 | -17.75% |
| Dec 31, 2022 | 462 | 152 | 49.03% |
| Dec 31, 2021 | 310 | 48 | 18.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| ACADIA Pharmaceuticals | 798 |
| Catalyst Pharmaceuticals | 182 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| CG Oncology | 142 |
| Erasca | 103 |
| NewAmsterdam Pharma Company | 100 |
TVTX News
- 1 day ago - Travere Therapeutics says Filspari generally well tolerated in Phase 3 study - TheFly
- 1 day ago - Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress - Business Wire
- 2 days ago - Travere Therapeutics price target raised to $62 from $59 at Citi - TheFly
- 2 days ago - Travere Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 days ago - Travere Therapeutics price target raised to $67 from $57 at H.C. Wainwright - TheFly
- 3 days ago - Travere Therapeutics Transcript: Investor update - Transcripts
- 3 days ago - Travere Therapeutics Press release: Investor update - Filings
- 3 days ago - Travere Therapeutics Slides: Investor update - Filings